138 related articles for article (PubMed ID: 12880723)
1. Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns.
Holder IA; Durkee P; Supp AP; Boyce ST
Burns; 2003 Aug; 29(5):445-8. PubMed ID: 12880723
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing.
Yin HQ; Langford R; Burrell RE
J Burn Care Rehabil; 1999; 20(3):195-200. PubMed ID: 10342470
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the penetration of nanocrystalline silver through various wound dressing mediums: An in vitro study.
Potgieter MD; Meidany P
Burns; 2018 May; 44(3):596-602. PubMed ID: 29290512
[TBL] [Abstract][Full Text] [Related]
5. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
[TBL] [Abstract][Full Text] [Related]
6. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study.
Innes ME; Umraw N; Fish JS; Gomez M; Cartotto RC
Burns; 2001 Sep; 27(6):621-7. PubMed ID: 11525858
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
[TBL] [Abstract][Full Text] [Related]
8. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.
Tredget EE; Shankowsky HA; Groeneveld A; Burrell R
J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial efficacy of a novel silver hydrogel dressing compared to two common silver burn wound dressings: Acticoat™ and PolyMem Silver(®).
Boonkaew B; Kempf M; Kimble R; Supaphol P; Cuttle L
Burns; 2014 Feb; 40(1):89-96. PubMed ID: 23790588
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
11. Use of Acticoat dressings in burns: what is the evidence?
Khundkar R; Malic C; Burge T
Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of three silver dressings in an infected animal model.
Heggers J; Goodheart RE; Washington J; McCoy L; Carino E; Dang T; Edgar P; Maness C; Chinkes D
J Burn Care Rehabil; 2005; 26(1):53-6. PubMed ID: 15640735
[TBL] [Abstract][Full Text] [Related]
13. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
[TBL] [Abstract][Full Text] [Related]
14. The antimicrobial spectrum of Xeroform
Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
[TBL] [Abstract][Full Text] [Related]
15. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
[TBL] [Abstract][Full Text] [Related]
16. Use of flow cytometry to compare the antimicrobial efficacy of silver-containing wound dressings against planktonic Staphylococcus aureus and Pseudomonas aeruginosa.
Percival SL; Slone W; Linton S; Okel T; Corum L; Thomas JG
Wound Repair Regen; 2011; 19(3):436-41. PubMed ID: 21518089
[TBL] [Abstract][Full Text] [Related]
17. The role of Acticoat with nanocrystalline silver in the management of burns.
Dunn K; Edwards-Jones V
Burns; 2004 Jul; 30 Suppl 1():S1-9. PubMed ID: 15327800
[TBL] [Abstract][Full Text] [Related]
18. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
[TBL] [Abstract][Full Text] [Related]
19. Acticoat dressings and major burns: systemic silver absorption.
Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of silver-containing antimicrobial dressings and drugs.
Castellano JJ; Shafii SM; Ko F; Donate G; Wright TE; Mannari RJ; Payne WG; Smith DJ; Robson MC
Int Wound J; 2007 Jun; 4(2):114-22. PubMed ID: 17651227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]